Abstract:Purpose: To investigate the role of arterial-spin labeling (ASL) MRI to non-invasively characterize the patterns of cerebral blood flow (CBF) changes in cirrhotic patients and to assess the potential of ASL MRI to characterize minimal hepatic encephalopathy (MHE).Materials and methods: This study was approved by the local ethics committee, and written informed consent was obtained from all participants. Thirty six cirrhosis patients without overt hepatic encephalopathy (16 MHE patients and 20 non hepatic encephalopathy (non-HE) patients) and 25 controls underwent ASL MRI, and CBF was measured for each subject. One-way ANOCOVA test with age and gender as covariences was used to compare CBF difference among three groups, and post hoc analysis was performed between each two groups. Region-based correlation analysis was applied between Child-Pugh score, venous blood ammonia level, neuropsychological tests and CBF values in cirrhosis patients. Receiver operator characteristic (ROC) analysis was used for assessing CBF measurements in ASL MRI to differentiate MHE from non-HE patients.Results: The gray matter CBF of MHE patients (71.09 +/- 11.88 mL min(-1) 100 g(-1)) was significantly higher than that of non-HE patients (55.28 +/- 12.30 mL min(-1) 100 g(-1), P < 0.01) and controls (52.09 +/- 9.27 mL min(-1) 100 g(-1), P < 0.001). Voxel-wise ANOCOVA results showed that CBFs were significantly different among three groups in multiple gray matter areas (P<0.05, Bonferroni corrected). Post hoc comparisons showed that CBF of these brain regions was increased in MHE patients compared with controls and non-HE patients (P<0.05, Bonferroni corrected). CBF of the right putamen was of the highest sensitivity (93.8%) and moderate specificity (75.0%) for characterization of MHE when using the cutoff value of 50.57 mL min(-1) 100 g(-1). CBFs in the bilateral median cingulate gyri, left supramarginal gyrus, right angular gyrus, right heschl gyrus and right superior temporal gyrus have both sensitivity and specificity of approximately 80% for the diagnosis of MHE.Conclusion: Higher CBF was found in many brain regions in cirrhotic patients than controls and gradually increased with the progress of disease. CBF measured with ASL MRI can be a useful marker for differentiating MHE from non-HE patients. (C) 2013 Elsevier Ireland Ltd. All rights reserved.

Research on Magnetic Resonance Perfusion Imaging in the Patients with Subclinical Hepatic Encephalopathy

Application of Contrast-Enhanced Perfusion MR Imaging in Patients with Subclinical Hepatic Encephalopathy

The Study of Arterial Spin Labeling Perfusion MR Imaging in the Patients with Subclinical Hepatic Encephalopathy

Dynamic Susceptibility Contrast-Enhanced First-Pass Perfusion MR Imaging in Patients with Subclinical Hepatic Encephalopathy.

Quantitative Study of Magnetization Transfer Imaging and Diffusion-Weighted Imaging of Brain in Patients with Liver Cirrhosis

Progress of Medical Imaging on Hepatic Encephalopathy

The Value of MRI and 1H - MRS in Patients with Minimal Hepatic Encephalopathy

MRI Appearances of Subclinical Hepatic Encephalopathy Related to Parkinsonian Symptoms

Clinical Research on Alterations of Brain MRI and 1H-MRS in Chronic Hepatic Disease

Structural and Functional Magnetic Resonance Imaging in Hepatic Encephalopathy

Research progress of BOLD-functional MRI of hepatic encephalopathy

The Evaluation of Image Signal Intensity Correction Using PURE Technique in Patients with Subclinical Hepatic Encephalopathy

MRI Evaluation of Cerebral Perfusion Changes in Patients with MELAS Syndrome

A Study of 3T Proton Magnetic Resonance Spectroscopy in Minimal Hepatic Encephalopathy

Multimodality Magnetic Resonance Imaging in Hepatic Encephalopathy: an Update.

Cerebral Blood Flow Measured by Arterial-Spin Labeling MRI: a Useful Biomarker for Characterization of Minimal Hepatic Encephalopathy in Patients with Cirrhosis.

Cerebral Metabolic Changes in Patients with Hepatic Cirrhosis:Magnetic Resonance Spectroscopic Study

Altered resting-state brain activity at functional MR imaging during the progressionof hepatic encephalopathy

MRI and MR Spectroscopy Study on Basal Ganglia Alterations in Patients with Liver Cirrhosis

T2*Mri of Minimal Hepatic Encephalopathy and Cognitive Correlates in Vivo

Clinical application of brain perfusion SPECT/CT imaging with NeuroGamTM software in subjective cognitive decline, mild cognitive impairment and Alzheimer's disease